Hirtle Callaghan & CO LLC Abb Vie Inc. Transaction History

Hirtle Callaghan & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $4,533 - $5,794	-69 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $5,322 - $6,264	69 New	69 $6,000
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $6,194 - $7,329	-69 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$89.56 - $98.21 $6,179 - $6,776	69	69 $7,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.